Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Mar;71(3):428–432.

Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon.

C Skoglund 1, A Scheynius 1, R Holmdahl 1, P H Van der Meide 1
PMCID: PMC1541681  PMID: 2454769

Abstract

During the delayed type of hypersensitivity (DTH) reaction in the skin, class II transplantation antigens are expressed on the keratinocytes. This induction is attributed to the action of gamma-interferon (IFN-gamma). We have now studied the influence of antibodies against IFN-gamma on the DTH-reaction. Lewis rats were sensitized to 2,4-dinitro-1-fluorobenzene (DNFB) and challenged 5 days later with DNFB on the ears. Immediately before challenge each animal in one group (n = 16) was given 1 mg of mouse monoclonal antibodies (MoAb) against rats IFN-gamma, denoted DB-1, intraperitoneally (i.p.), another group (n = 15), 1 mg of an irrelevant MoAb and a third group (n = 11) was left untreated. The ear thickness was measured with a micrometer, before challenge and after 24, 48 and 72 h. At 72 h all rats were killed, the ears cut off, snap frozen and stained with immunoperoxidase using MoAbs OX 6 and OX 17, directed against rat class II antigens. The DB-1 treated group was found to have a larger ear swelling that was statistically significant at each time point compared with the other two groups. Furthermore, the animals given DB-1 showed class II antigen expression on Langerhans' cells, but almost none on keratinocytes. In contrast, the rats in the two other groups displayed a moderate to strong expression of class II antigens on keratinocytes as well as on Langerhans' cells. It is concluded that DB-1 can inhibit class II antigen expression on keratinocytes during the DTH- reaction and also enhance the local response.

Full text

PDF
431

Images in this article

430Fig. 2
on p.430

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basham T. Y., Nickoloff B. J., Merigan T. C., Morhenn V. B. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol. 1984 Aug;83(2):88–90. doi: 10.1111/1523-1747.ep12262597. [DOI] [PubMed] [Google Scholar]
  2. Bianchi A. T., Hooijkaas H., Benner R., Tees R., Nordin A. A., Schreier M. H. Clones of helper T cells mediate antigen-specific, H-2-restricted DTH. Nature. 1981 Mar 5;290(5801):62–63. doi: 10.1038/290062a0. [DOI] [PubMed] [Google Scholar]
  3. Braathen L. R., Thorsby E. Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol. 1980;11(4):401–408. doi: 10.1111/j.1365-3083.1980.tb00006.x. [DOI] [PubMed] [Google Scholar]
  4. Collart M. A., Belin D., Vassalli J. D., de Kossodo S., Vassalli P. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med. 1986 Dec 1;164(6):2113–2118. doi: 10.1084/jem.164.6.2113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fukumoto T., McMaster W. R., Williams A. F. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol. 1982 Mar;12(3):237–243. doi: 10.1002/eji.1830120313. [DOI] [PubMed] [Google Scholar]
  6. Groenewegen G., Buurman W. A., van der Linden C. J. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature. 1985 Jul 25;316(6026):361–363. doi: 10.1038/316361a0. [DOI] [PubMed] [Google Scholar]
  7. Kaplow I. S. Letter: Substitute for benzidine in myeloperoxidase stains. Am J Clin Pathol. 1975 Mar;63(3):451–451. doi: 10.1093/ajcp/63.3.451. [DOI] [PubMed] [Google Scholar]
  8. Klareskog L., Holmdahl R., Rubin K., Victorin A., Lindgren J. A. Different populations of rheumatoid adherent cells mediate activation versus suppression of T lymphocyte proliferation. Arthritis Rheum. 1985 Aug;28(8):863–872. doi: 10.1002/art.1780280805. [DOI] [PubMed] [Google Scholar]
  9. Krammer P. H., Echtenacher B., Gemsa D., Hamann U., Hültner L., Kaltmann B., Kees U., Kubelka C., Marcucci F. Immune-interferon (IFN-gamma), macrophage-activating factors (MAFs), and colony-stimulating factors (CSFs) secreted by T cell clones in limiting dilution microcultures, long-term cultures, and by T cell hybridomas. Immunol Rev. 1983;76:5–28. doi: 10.1111/j.1600-065x.1983.tb01095.x. [DOI] [PubMed] [Google Scholar]
  10. Matis L. A., Glimcher L. H., Paul W. E., Schwartz R. H. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A. 1983 Oct;80(19):6019–6023. doi: 10.1073/pnas.80.19.6019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McMaster W. R., Williams A. F. Monoclonal antibodies to Ia antigens from rat thymus: cross reactions with mouse and human and use in purification of rat Ia glycoproteins. Immunol Rev. 1979;47:117–137. doi: 10.1111/j.1600-065x.1979.tb00291.x. [DOI] [PubMed] [Google Scholar]
  12. Noma T., Dorf M. E. Modulation of suppressor T cell induction with gamma-interferon. J Immunol. 1985 Dec;135(6):3655–3660. [PubMed] [Google Scholar]
  13. Scheynius A., Johansson C., van der Meide P. H. In vivo induction of Ia antigens on rat keratinocytes by gamma-interferon. Br J Dermatol. 1986 Nov;115(5):543–549. doi: 10.1111/j.1365-2133.1986.tb05763.x. [DOI] [PubMed] [Google Scholar]
  14. Scheynius A., Klareskog L., Forsum U., Matsson P., Karlsson L., Peterson P. A., Sundström C. Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting. J Invest Dermatol. 1982 Jun;78(6):452–455. doi: 10.1111/1523-1747.ep12510125. [DOI] [PubMed] [Google Scholar]
  15. Scheynius A., Tjernlund U. Human keratinocytes express HLA-DR antigens in the tuberculin reaction. Scand J Immunol. 1984 Feb;19(2):141–147. doi: 10.1111/j.1365-3083.1984.tb00910.x. [DOI] [PubMed] [Google Scholar]
  16. Schultz R. M., Kleinschmidt W. J. Functional identity between murine gamma interferon and macrophage activating factor. Nature. 1983 Sep 15;305(5931):239–240. doi: 10.1038/305239a0. [DOI] [PubMed] [Google Scholar]
  17. Stingl G., Katz S. I., Clement L., Green I., Shevach E. M. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol. 1978 Nov;121(5):2005–2013. [PubMed] [Google Scholar]
  18. Suitters A. J., Lampert I. A. Expression of Ia antigen on epidermal keratinocytes is a consequence of cellular immunity. Br J Exp Pathol. 1982 Apr;63(2):207–213. [PMC free article] [PubMed] [Google Scholar]
  19. van der Meide P. H., Dubbeld M., Vijverberg K., Kos T., Schellekens H. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J Gen Virol. 1986 Jun;67(Pt 6):1059–1071. doi: 10.1099/0022-1317-67-6-1059. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES